pd 98059 has been researched along with Heart Diseases in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bopassa, JC | 1 |
Eghbali, M | 1 |
Toro, L | 1 |
Stefani, E | 1 |
Chen, MM | 1 |
Lam, A | 1 |
Abraham, JA | 1 |
Schreiner, GF | 1 |
Joly, AH | 1 |
2 other studies available for pd 98059 and Heart Diseases
Article | Year |
---|---|
A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury.
Topics: Adenosine Triphosphate; Animals; Blotting, Western; Enzyme Inhibitors; Extracellular Signal-Regulate | 2010 |
CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis.
Topics: Adult; Aged; Animals; Animals, Newborn; Biomarkers; Blotting, Northern; Cells, Cultured; Colforsin; | 2000 |